EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Management of Tuberculosis Infection: Current Situation, Recent Developments and Operational Challenges

Gino Agbota iD, Maryline Bonnet iD, Christian Lienhardt

Pathogens · 21.02.2023 · 12 (3) · 362

DOI: 10.3390/pathogens12030362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 21.02.2023. Verfasst von Gino Agbota und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Montpellier, TransVIHMI, Institut de Recherche pour le Développement (IRD), Institut National de la Santé et de la Recherche Médicale (…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis infection (TBI) is defined as a state of infection in which individuals host live Mycobacterium tuberculosis with or without clinical signs of active TB. It is now understood as a dynamic process covering a spectrum of responses to infection resulting from the interaction between the TB bacilli and the host immune system. The global burden of TBI is about one-quarter of the world’s population, representing a reservoir of approximately 2 billion people. On average, 5–10% of people who are infected will develop TB disease over the course of their lives, but this risk is enhanced in a series of conditions, such as co-infection with HIV. The End-TB strategy promotes the programmatic management of TBI as a crucial endeavor to achieving global targets to end the TB epidemic. The current development of new diagnostic tests capable of discriminating between simple TBI and active TB, combined with novel short-course preventive treatments, will help achieve this goal. In this paper, we present the current situation and recent developments of management of TBI and the operational challenges.

Schlagwörter

Stichwörter der Autor:innen

TB high- and low-burden countriesTB infectionTB preventive therapyWHO recommendationscost-effectiveness

Autor:innen und Institutionen

  • University of Montpellier, TransVIHMI, Institut de Recherche pour le Développement (IRD), Institut National de la Santé et de la Recherche Médicale (INSERM), 34090 Montpellier, France.
  • Institut de Recherches Cliniques du Bénin (IRCB), Abomey-Calavi, Benin.
  • Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

ORCID-Profile: Gino Agbota, Maryline Bonnet

Zitieren

APA

Agbota, G., Bonnet, M., & Lienhardt, C. (2023). Management of Tuberculosis Infection: Current Situation, Recent Developments and Operational Challenges. Pathogens, 12(3), 362. https://doi.org/10.3390/pathogens12030362

Vancouver

Agbota G, Bonnet M, Lienhardt C. Management of Tuberculosis Infection: Current Situation, Recent Developments and Operational Challenges. Pathogens. 2023;12(3):362. doi:10.3390/pathogens12030362

BibTeX
@article{Agbota2023,
  author = {Agbota, Gino and Bonnet, Maryline and Lienhardt, Christian},
  title = {Management of Tuberculosis Infection: Current Situation, Recent Developments and Operational Challenges},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {362},
  doi = {10.3390/pathogens12030362}
}
Kostenlos starten →